United States · Artificial Intelligence (AI) startup
United States · 1910 Genetics Inc.
1910 genetics is a Massachusetts-based AI-driven drug discovery platform for pharmaceutical researchers to optimize the design of small molecule and protein therapeutics.
Funding reportedLast round: Grant
What company datasets say 1910 Genetics Inc. raised
Funding, as reported
Founders and team
From the SEC filings it signed: 1 on the team.
- Jennifer O. NwankwoExecutive Officer, Directori
On the board, as filediJory O. BellMarc O. FosterSamir O. Kumar
On 5 portfolio pages
Investors who name them
Each firm lists 1910 Genetics Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
customized ai architectureshospital & health carehealth carepaaspharmaceutical partnersbiopharma collaborationadmet predictionsystematic drug designstate-of-the-art roboticsrobotics-driven labco-discovery modeldata scarcity resolutionfederated learningsmall moleculeomic data integrationcomputational data
Built with from their website
Microsoft 365Amazon AWSAmazon SESAWS SDK for JavaScriptGoogle WorkspaceReactVueJSSlackAmazon Route 53Greenhouse
+1 more
Gmail
- Sector
- Artificial Intelligence (AI)
- Industry code
- NAICS 54171, SIC 2834
- Region
- Massachusetts
- Revenue
- $5.0M a year, as listed
- Full record
- Every detail in the company directory
Artificial Intelligence (AI) in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put 1910 Genetics Inc. in front of investors. Or tell us what we have wrong.